← Open Payments lookup

ANAND BOSMIA: Open Payments

NPI 1235525395 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,352 in 90 payments from 11 companies in 2025. Trend: 2023 $611 · 2024 $1,254 · 2025 $1,352

Food & beverage: $1,218Education: $135
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.26$341
E.R. Squibb & Sons, L.L.C.17$226
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$190
Alkermes, Inc.18$176
Teva Pharmaceuticals USA, Inc.3$139
Otsuka America Pharmaceutical, Inc.5$112
Vanda Pharmaceuticals Inc.4$82
ABBVIE INC.2$36
Luye Pharma (USA) Ltd.1$18
Indivior Inc.1$18

Products named: INGREZZA, COBENFY, CAPLYTA, ARISTADA, FANAPT, ABILIFY ASIMTUFII, REXULTI, VRAYLAR.

Industry payments across LA — which companies pay providers there.